ICUCW
SeaStar Medical Holding Corporation
NASDAQ · Healthcare · Biotechnology · US
$0.02
+0.00%Price chart
Aug 5Aug 10Aug 13Aug 18Aug 24Aug 27Sep 1Sep 4
ValuationView details →
P/E (Fwd)
—
EV/EBITDA
0.5x
Market Cap
$43021.24
MomentumView details →
1D Return
+0.00%
YTD Return
+44.25%
RSI (14)
42.7
ValuationView details →
P/E (Fwd)
—
EV/EBITDA
0.5x
Market Cap
$43021.24
RSI (14)
42.7
MomentumView details →
1D Return
+0.00%
YTD Return
+44.25%
Similar companies
Latest newsMore news →
SeaStar Medical Holding Corporation expanded adoption of its QUELIMMUNE product to 20 of 50 premier children's hospitals, targeting 25 by year-end.23d agoSeaStar Medical reported its second quarter 2026 financial results, with net revenue up 82% versus the second quarter of 2025, and added three top-rated children's hospitals to its QUELIMMUNE pediatric acute kidney injury customer base.23d ago